Skip to main content
Premium Trial:

Request an Annual Quote

MorphoSys Raises $20.6M in Stock Placement

NEW YORK, March 29 (GenomeWeb News) - MorphoSys has raised around17.1 million ($20.6 million) after placing 384,338 shares with international institutional investors, the company said today.

 

MorphoSys priced the shares at44.50 apiece. The issue was several times over-subscribed, the company said.

 

The company said the proceeds will enable it to raise its cash balance to approximately60 million. Additionally, the funding "allows us the flexibility to further expand the research antibody side of our business," CFO Dave Lemus said in a statement.

 

WestLB AG acted as lead manager of the transaction with DZ BANK as co-lead manager.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.